Key result
Onyx embolization achieves ~100% initial sealing of type 1 endoleaks despite late rupture risk.
Why the study?
Does Onyx embolization seal type 1 endoleaks in patients undergoing endovascular aortic repair?
Observational (n=6)
Does Onyx embolization seal type 1 endoleaks in patients undergoing endovascular aortic repair?
Onyx embolization is a promising bailout solution for type 1 endoleaks after complicated EVAR, but it does not prevent late stentgraft migration.
Onyx may support acute type 1 endoleak sealing post-EVAR; leaves open durability and migration risk in larger prospective studies.
The aim of this study was to investigate whether the liquid embolic agent Onyx, an ethylene vinyl alcohol copolymer, can be used to seal type 1 endoleaks during endovascular aortic repair (EVAR). Six patients with large aortic aneurysms and remaining type 1 endoleaks during or after EVAR were treated with Onyx embolization through a microcatheter placed in the proximal neck in five cases and in the distal neck in one case. Four of the patients were treated using the chimney technique. The type 1 endoleak was primarily sealed by Onyx in all six patients. There was no distal embolization. Two patients had complications during follow-up. One patient had occlusions of chimney grafts to the renal arteries and to one leg extension. These occlusions were not anatomically related to Onyx embolization. One patient had late stentgraft migration of the Onyx-treated distal neck with aneurysm rupture 18 months after treatment. Early experience of Onyx embolization as a bailout solution of type 1 endoleaks after complicated EVAR is promising. However, effective seal with Onyx does not prevent late stentgraft migration. More reported patients and longer follow-up are necessary to evaluate this new technique.
No takes yet. Share an insight, caveat, or question.
Henrikson et al. (2011) conducted an observational in Type 1 endoleaks during or after EVAR (n=6). Onyx (ethylene vinyl alcohol copolymer) embolization was evaluated on Primary seal of type 1 endoleak. Onyx embolization successfully sealed type 1 endoleaks in 100% (6/6) of patients, though one patient experienced late stentgraft migration and aneurysm rupture at 18 months.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: